The bull market turned six-years-old this week, which is pretty amazing. It’s been quite a ride. In that time, the Dow Jones Industrial Average has charged ahead more than 150%, the S&P 500 180% and Nasdaq 250%. One group that has been at the forefront of this bull market is biotech stocks.Source: FlickrIn fact, the past five years have been […]
When the market gets a little sketchy, investors might tend to prefer the “blue chip” companies vs. the smaller companies due to the perceived safety in the bigger names.To isolate those bigger names, the most common method is by searching for companies with the largest market capitalization.Market cap is defined as the total dollar market value of all of a […]
There’s nothing better than getting a great value — and let’s face it, when the market tumbles, often great stocks get crushed too. That could end up being particularly true in biotech. Since 2013, the industry’s return has tripled the S&P 500’s return, and that may mean that with the market slipping lately, biotech’s leading names — including Celgene — […]
Gilead, without a doubt, has proven itself to be a leader in the biotechnology industry. The stock has had an extremely bullish pattern over the last four years, growing over 400% in stock price since March 2011. However, over the last 6 months, the stock has seen a loss of about 5%.In fact, there has been a considerable amount of […]
The Nasdaq composite remains heavily weighted toward technology, thanks to Apple’s record market valuation near $750 billion. But tech’s weighting is down sharply from the Nasdaq’s peak, while the financial, consumer services and health-care sectors have seen their weightings more than double within the composite. [See table below.]Health care’s weighting in the composite is now 16 percent, which is comparable […]
You may have already been aware that the biotechnology sector has been hot over the past several years. But have you seen it lately? While most other sectors have been trending sideways, or even down as in the case of energy, the biotechnology sector has been absolutely on fire – with the largest biotech ETF iShares Nasdaq Biotechnology (NASDAQ: IBB) […]
Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.Copyright ©2015 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.
Original article:
3 Biotech Stocks for Short-Term, Bullish Trades | InvestorPlace
[…]
Who can beat the ‘superbug’?
A new antibiotic-resistant “superbug” may have contributed to the deaths of 2 patients at Ronald Reagan-UCLA Medical Center. What companies may be on track to combat the deadly virus, with CNBC’s Meg Tirrell.
A year ago, Receptos was a billion-dollar company looking to compete with drugmakers sometimes a hundred times its size, in therapeutic areas already served […]
For some time now, Europe’s economy has been traversing rough waters. Economic data has been disappointing and geopolitical tensions have kept investors worried. While an uneasy truce has been reached on Ukraine, Greece debt negotiations remain unresolved. But new economic data and stock market performance indicate that it may a good time to buy into Europe after all.Markets Moving NorthMarkets […]
Preface: The biotech stocks considered for this review were confined to those over $10 per share that traded at least 500K shares a day based on a 90-day average.For the longest time it seemed that for every new high the S&P 500 hit, biotech stocks, as measured by the iShares Nasdaq Biotechnology Index (NASDAQ: IBB), hit two new highs.Biotechnology […]
